Continuing Education Workshops


CE Credit for the live summit is now closed.

Stay tuned for future CE opportunities. 

CE Program Accreditation and Disclosures

The International Neuropsychological Society is approved by the American Psychological Association to sponsor continuing education for psychologists. The International Neuropsychological Society maintains responsibility for this program and its content. Up to 6.0 credit hours are available for this program. All CE sessions are geared for advanced level instructional activity.

Due to the economic impact associated with COVID-19, we are offering quality CE workshops at discounted rates:

  • Professionals: $25/CE
  • INS members: 20% OFF($20/CE) with coupon code available on the INS Member site
  • Professionals from low-income countries / Students: 50% OFF ($12.50/CE)
  • We are offering a free registration without CE
Purchase the 6 CE Workshop Bundle to receive an additional 35% OFF!
  • The countries listed below are considered low-income per the World Bank Atlas method.
  • If you live in a country listed then you qualify for the low-income professional rate.

Burkina Faso
Cabo Verde
Central African Republic
Congo, Dem. Rep.
Congo, Rep.
Côte d’Ivoire
Egypt, Arab Rep.
El Salvador
Gambia, The
Korea, Dem. People’s Rep.
Kyrgyz Republic
Micronesia, Fed. Sts.
Papua New Guinea
São Tomé and Principe
Sierra Leone
Solomon Islands
South Sudan
Syrian Arab Republic
West Bank and Gaza
Yemen, Rep.

Workshop #1

Innovations in Neuropsychological Assessment

9:00am - 12:00pm EST | 3.0 CE credits


During this challenging time, it is more apparent than ever before that the convergence between brain science and technology with a global and interdisciplinary perspective is key to innovation. Toward that end, this course will describe recent advances in the applications of technology for neuropsychological assessment in the following areas: 1) We will address the modulating effect of culture to explain differences in neurocognitive performance among people from different cultures, ethnicities or minorities. The EMBRACED project will be presented as the first culturally adapted computerized neuropsychological battery for the assessment of adults worldwide and demonstrate the increased diagnostic utility of incorporating cultural factors into assessment batteries. 2) The next part of the presentation will highlight the latest advances in the identification of neurocognitive deterioration and dementia in the elderly through remote and mobile neuropsychological assessments. 3) The last part of the course will include a moderated Tele-Neuropsychology (TeleNP) Expert Panel that will highlight the state of the art in TeleNP practice, research, and service delivery across settings around the world with special attention given to diverse populations, new opportunities, risks/limitations, and short- and long-term benefits of TeleNP.

Learning Objectives

After this workshop, you will be able to:
  1. List new techniques in computerized assessment and tele-neuropsychology for linguistically and ethnically diverse populations
  2. Discuss the detection of cognitive symptoms within the context of effective remote and technology-assisted assessments
  3. Apply at least three strategies and tools for tele-neuropsychology practice, research, and service delivery
  4. Critique the advantages and disadvantages of traditional versus technology-assisted approaches to neuropsychological assessment

Speaker Biography

Antonio E. Puente, PhD was born in La Habana, Cuba and emigrated to the US in 1960. Dr. Puente received his Ph.D. from the University of Georgia. He has taught at University of North Carolina Wilmington (UNCW) since 1981 and prior to that at St. Georges University School of Medicine. His primary teaching activities include Brain and Behavior, Clinical Neuropsychology and History of Psychology. Dr. Puente is founding director of UNCW’s Centro Hispano and his research focuses on the interface between culture and neuropsychology. Puente founded and edited the journals Neuropsychology Review and Journal of Interprofessional Education &
Practice as well as a neuropsychology book series. He has published 10 books, 85 chapters and 112 scientific articles in several languages. Dr. Puente is Professor of Psychology at the University of North Carolina Wilmington and also maintains a private practice in clinical neuropsychology is the founder and co-director of mental health services at the Cape Fear Clinic, a bilingual multi-disciplinary health center serving the indigent. Dr. Puente served as president of the N.C. Psychological Association, N.C. Psychological Foundation, the Hispanic Neuropsychological Association, National Academy of Neuropsychology, and Society for Clinical Neuropsychology (Division 40 of APA) as well as President of the American Psychological Association.

Dr. Inmaculada Ibanez-Casas serves as an Assistant Professor in the Department of Psychology and a Neuropsychologist at the Center of Neurobehavioral Health at the State University of New York at Plattsburgh. Dr. Ibanez-Casas is best known for her work in cross-cultural neuropsychology particularly in the Hispanic population in the US, including being the creator and principal investigator of the EMBRACED© project, that has developed the first culturally sensitive neuropsychological battery administered in an iPad in the world. She has more than 10 years’ experience in the field and has authored or co-authored more than 40 publications including papers, books, book chapters and conference proceedings, and presents regularly at state, national, and international conferences. She has received grant funding from the American Psychological Association, the Spanish regional and national government, and other organizations. Among those, she was awarded the very prestigious Marie Skłodowska Curie Individual Fellowship from the European Commission to fund her EMBRACED Project. Dr. Ibanez-Casas is an active member of the American Psychological Association and its divisions 2 (Society for the Teaching of Psychology), 40 (Society for Clinical Neuropsychology), 45 (Society for the Psychological Study of Culture, Ethnicity, and Race), and 52 (International Psychology), and collaborates with other important associations such as the Hispanic Neuropsychological Society. She received her PhD in neuroscience from the University of Granada (Spain) in 2011, where she also received her master’s degrees in health psychology, assessment and psychological treatment (2008), and in clinical psychology (2018). She can be contacted at
Jason Hassenstab, PhD, is an Associate Professor of Neurology and of Psychological and Brain Sciences and the director of the Cognitive Technology Research Laboratory (CTRLab) at Washington University in St. Louis. He also leads the Cognition Cores for the Dominantly-Inherited Alzheimer Network-Trials Unit (DIAN-TU) and the DIAN observational study and the Charles F. and Joanne Knight Alzheimer’s Disease Research Center. The CTRLab’s focus in on using technology to improve cognitive assessments in Alzheimer’s disease and other disorders. We use measurement burst designs, based on principles from ecological momentary assessment, to measure cognition rapidly and frequently on smartphones in normal and clinical populations. We also develop web-based cognitive assessments designed to be sensitive to the very earliest stages of neurodegenerative disease. Dr. Hassenstab has been continuously funded by the NIH since 2007, and also receives funding from foundations. His most recent projects include development of the Ambulatory Research in Cognition (ARC) smartphone application for the DIAN observational study, the DIAN-TU Phase III clinical trials, and the Healthy Aging and Senile Dementia program project grant at the Knight ADRC. Prior to pursuing academics, Dr. Hassenstab toured internationally as a professional jazz saxophonist, often sporting a purple pinstriped zoot suit, and made hundreds of dollars. He completed a bachelor’s degree in Jazz and Contemporary Music Performance at New York University and a PhD in psychology under mentorship of Dr. Antonio Convit at New York University and Fordham University. He then completed a Fellowship at Brown University and joined the faculty at Washington University in St. Louis in 2010.
Robert M Bilder, PhD, ABPP-CN is the Michael E. Tennenbaum Family Distinguished Professor of Psychiatry & Biobehavioral Sciences, Chief of Psychology at UCLA’s Jane & Terry Semel Institute for Neuroscience and Human Behavior, and Director of the Tennenbaum Center for the Biology of Creativity. His research has focused on the links between brain and behavior, using tools spanning genetics, neuropsychopharmacology, neuroimaging, neurophysiology, cognitive, symptomatic, and syndromal assessments of human behavior. He is interested in studying dimensions of brain function to help eliminate artificial boundaries between mental illnesses, between health and disease, and between the brain mechanisms involved in exceptional and everyday creativity. To advance these goals for clinical neuropsychology, he serves as overall project director for the National Neuropsychology Network, and NIMH-sponsored multi-site program that aims to establish infrastructure for neuropsychology clinics to gather common data elements and deposit item-level data from clinical assessments into the NIMH Data Archive. He also directs the Mind Well pod within UCLA’s Healthy Campus Initiative to concentrate on how we can support resilience, well-being and creative achievement at UCLA and beyond. Of special relevance to this presentation, he leads the Disruptive Technology Initiative for the American Academy of Clinical Neuropsychology, and chaired the writing group for the Inter Organizational Practice Committee ( guidance and recommendations for teleneuropsychology.
Dr. Munro Cullum is professor of Psychiatry, Neurology, and Neurological Surgery at the University of Texas Southwestern Medical Center, where he also serves as Vice Chair of Psychiatry and Senior Neuropsychologist in the Peter O'Donnell Brain Institute and holds the Pamela Blumenthal Professorship in Clinical Psychology. He is board certified in clinical neuropsychology (ABPP) and is a past-president of the National Academy of Neuropsychology and the Society for Clinical Neuropsychology (APA Division 40), has served on the governing boards of INS and AACN, and is the incoming president of the Sports Neuropsychology Society (SNS). Dr. Cullum is involved in research, education, administration, and clinical service delivery in neuropsychology. In addition to his research contributions in the areas of concussion and neurodegenerative conditions, he conducted the largest study of teleneuropsychology (TeleNP) to date, and his research has demonstrated the feasibility, reliability, validity, and acceptability of this medium of remote assessment in different populations, in addition to offering preliminary guidelines on TeleNP practice.
Dr. Woods is a Professor of Psychology (Clinical Neuropsychology) at the University of Houston and an Adjunct Professor of Psychological Science at the University of Western Australia. His program of research uses cognitive theory to enhance the clinical detection, prediction, and remediation of real- world health outcomes in various neuropsychological populations, including HIV disease and aging. In particular, he is interested in the neuropsychological and functional aspects of internet navigation skills, health literacy, and prospective memory. He is currently an Associate Editor at Neuropsychology and The Clinical Neuropsychologist. Dr. Woods also directs a weekly neuropsychology consultation clinic for persons with HIV disease at the Thomas Street Health Center in Houston, Texas.
Heidi Allison Bender, Ph.D. is an Associate Professor of Neurology and Psychiatry within the Icahn School of Medicine at Mount Sinai. She has been the recipient of multiple federally- and foundationally-funded research grants and training awards aimed at improving the diagnostic parameters, treatment regimens, and overall quality of care provided to adults and children with a wide variety of neurological challenges. Clinically, a Board Certified neuropsychologist and Director of Neuropsychological Services at the Mount Sinai Epilepsy Center, Dr. Bender specializes in the assessment and treatment of surgical candidates (both Spanish-and English-speaking) throughout the lifespan. In addition, Dr. Bender has provided cognitive remediation via and other therapies to individuals with neuromedical and neuropsychiatric disorders via telemedicine for many years and has a deep appreciation for the many applications of technology in order to remove barriers to patient care.

Dr. Cristi Salinas is a bilingual neuropsychologist who has improved the lives of over 6,000 children and adults from over 24 countries around the world. Major milestones in Dr. Cristi’s career include working with cutting-edge, neurodiagnostic technologies at Boston Children’s Hospital, and contributing to the development of best practices at Harvard Medical School, Emory Medical School, and Advent Health, particularly in the areas of epilepsy/brain tumor, sports concussion, fMRI, and BCI/ECoG language mapping. She is Assistant Professor of Psychiatry at UCF Medical School and Adjunct Assistant Professor in Psychology at Florida Institute of Technology. Dr. Cristi has first or co-authorship on 28 peer-reviewed articles and book chapters, as well as 35 invited national and international presentations. Dr. Salinas was selected as the 2019 Recipient of the Mentoring in Cultural Neuropsychology Award by the Hispanic Neuropsychological Society (HNS) and she currently serves on their Executive Board as Treasurer. She is the Founder of Neuropsychology Concierge® where she is among the country’s first neuropsychologists to provide innovative services such as on-demand, at-home, and tele-neuropsychology (TeleNP) since 2016. She is the Founder of Niños Health®, a 501c3 nonprofit organization dedicated to providing innovative, culturally responsive care, research, and education for Latinx and other underserved children who are struggling with conditions that affect development. Dr. Cristi is the Founder of the Brain Tech Project.

Workshop #2

Innovations in Neuroimaging Modalities

12:30pm - 2:00pm EST | 1.5 CE credits


This course will highlight translational research and innovations in human brain mapping in order to understand complex diseases across the lifespan. In clinical neurology, patients can present with the exact same group of symptoms (autism, generalized seizures called infantile spasms) despite a disparate distribution of causal focal lesions, including strokes, tumors, or malformations of cortical development. Through a novel approach called lesion network mapping (LNM), Dr. Peters will demonstrate how shared network properties of specific phenotypes can be identified. He will also present some forward-looking ideas about the application of deep learning and medical crowd-sourcing to tackle rare diseases like Tuberous Sclerosis Complex. Epilepsy surgery often remains the only possible treatment option to achieve seizure freedom and improve quality of life in patients with pharmacoresistant epilepsy. However, the overlap between the resection site and a neural substrate supporting language and motor functions might result in severe post-surgical deficits. To avoid pos-surgical morbidity and expand surgical treatment options, the innovative adaptive neurotechnology approaches, powered by machine learning and deep learning algorithms, are being developed to create functional maps in real-time and guide epilepsy surgery. Dr. Korostenskaja will discuss the current state of this technological development in the field of epilepsy and tumor surgery and its future perspectives. Finally, Dr. Quiroz will discuss recent developments in biomarkers of preclinical Alzheimer’s disease, including her group’s work with autosomal dominant Alzheimer’s disease, multimodal neuroimaging methods and digital assessments.

Learning Objectives

After this workshop, you will be able to:
  1. Explain the value of biomarkers and cognitive measures to diagnosis epilepsy and dementia
  2. Compare “gold” standard ESM to ECoG-based language mapping with deep learning approaches for pre-surgical planning
  3. List cognitive outcomes in cognitively-unimpaired carriers with familial Alzheimer’s disease

Speaker Biography

Jurriaan M. Peters MD, PhD, is a pediatric epileptologist with additional expertise in clinical neurophysiology and neuroimaging. He is an assistant in Neurology at Boston Children’s Hospital, and an Assistant Professor of Neurology at Harvard Medical School. He is the principal epileptologist at the Multidisciplinary Tuberous Sclerosis Program at Boston Children’s Hospital. His research is aligned with his clinical interests, and focuses on (1) the clinical application of novel MRI and EEG modeling techniques in the localization of the seizure onset zone in children with medically refractory epilepsy; (2) understanding how focal seizures over time evolve into a generalized epileptic encephalopathy; (3) elucidating the brain networks that allow for focal lesions to give rise to generalized seizures and (4) investigating if early treatment for epilepsy including preventative medication and early epilepsy surgery mitigate detrimental effects from seizures on neurodevelopment.

Milena Korostenskaja, Ph.D. is Founder and Director of The Institute of Neuroapproaches. She leads Brain-Computer Interface (BCI) program at AdventHealth Orlando and teaches in Associate Professor capacity at Vilnius University as well as serves as a Part-time Faculty at the University of North Florida and AdventHealth University. She received her Ph.D. in Psychology (Behavioral Sciences) from Helsinki University and completed her post-doctoral fellowship in neurophysiological research at the Department of Neurology, Cincinnati Children Hospital Medical Center, where she later received her first Faculty position as an Assistant Professor.  Her recent work focuses on finding biomarkers for neurological and mental disorders by using brain imaging techniques and developing effective treatment and rehabilitation approaches to alleviate the burden associated with these disorders by using BCIs. Currently, she is the principal investigator on several projects, including the project that aims to restore motor function in patients post-stroke by using BCIs, as well as to prevent post-surgical morbidity in patients undergoing brain surgery by using adaptive neurotechnologies.

Dr. Quiroz is Assistant Professor in the Departments of Psychiatry and Neurology at Massachusetts General Hospital and Harvard Medical School in Boston, MA. She is the Director of the Mass General Familial Dementia Neuroimaging Lab, and the Multicultural Alzheimer’s Prevention Program-MAPP. She earned her bachelor’s degree at the University  of Antioquia (Medellin, Colombia), and her PhD in clinical psychology at Boston University. She completed a postdoctoral fellowship in neuropsychology and brain imaging at MGH, under the mentorship of Drs. Reisa Sperling, Janet Sherman and Keith Johnson.   Dr. Quiroz’s research interests include brain imaging and genomics, and early detection and tracking of Alzheimer’s disease and other dementias.  She is the principal investigator of the Colombia-Boston (COLBOS) longitudinal biomarker study on familial Alzheimer’s disease. Dr. Quiroz's research has contributed to our understanding of preclinical Alzheimer's disease and neural mechanisms of cognitive ageing.  Her most recent work has focused on examining the role of ApoE in both cognitive impairment and protection against dementia and neurodegeneration in familial Alzheimer’s disease.  She has earned several awards throughout her career, including an NIH Director’s Early Independence Award, the FABBS Foundation Early Career Impact Award, and the National Academy of Neuropsychology Tony Wong Diversity Award.

Workshop #3

Innovations in Neurorehabilitation

2:00pm - 3:30pm EST | 1.5 CE credits


This workshop will describe innovations in the applications of technology for neurorehabilitation and treatment across diverse patient populations and settings around the world. First, Dr. Arango will highlight the state of the art and science in the area of technology and neurorehabilitation for individuals with traumatic brain injury (TBI). The advantages and disadvantages of using technology in rehabilitation will be addressed. Practical implications of the use of technology and future considerations with new frontiers will be explored. Dr. Beidel will discuss the use of virtual reality (VR) to treat post-traumatic stress disorder (PTSD). Beginning with the results of a large controlled trial for combat PTSD, the presentation will address the advantages and disadvantages of the current systems as well as preview the development of a new system designed to address a wide range of traumatic events. Lastly, a technical primer for brain health professionals will be presented. It provides an overview of the open-source, big data-oriented components and machine learning (ML) capabilities that provide automation of any of the manual workflows associated with detection and diagnosis, treatment, support, research and clinical administration practices performed by brain health providers.

Learning Objectives

After this workshop, you will be able to:
  1. Compare the advantages and disadvantages of using technology in the rehabilitation of individuals with brain injury
  2. Rate outcomes of incorporating virtual reality (VR) environments into exposure therapy for post-traumatic stress disorder (PTSD)
  3. List pre-assembled Open Source Applications for Brain Health

Speaker Biography

Dr. Juan Carlos Arango-Lasprilla is currently a Research Professor at BioCruces Vizcaya Health Research Institute in Bilbao, Spain. He has been instrumental in securing over $7 million dollars in grant funding as PI and co-PI. Dr. Arango has received many awards for his accomplishments in the area of neuropsychology including awards from the National Academic of Neuropsychology, the American Psychological Association, the International Brain Injury Association, the International Neuropsychological Society and The American Congress of Rehabilitation Medicine. He has published more than 300 articles and book chapters and edited 10 books.  Dr. Arango has been a guest editor of 12 special issues in prominent rehabilitation journals.  Dr. Arango has lectured at Grand Rounds at more than 95 different universities across the globe. He organized and chaired 4 international conferences on neuropsychology, cultural issues and Brain Injury Rehabilitation. Dr. Arango is a founding member of the Colombian Neuropsychological Society, and he founded the IberoAmerican Journal of Neuropsychology. His research focuses on understanding and addressing the cognitive, psychological, and emotional needs of individuals with brain injury and their families. He is particularly interested in under-served populations, such as Spanish speakers, and carries out research in the US, Europe, and Latin America. He was PI of a large, multi-center norming study in which more than 14,000 adults and children from over 15 Latin American countries. Thanks to his leadership, normative data by country is now available for the 12 most commonly used neuropsychological tests in each respective population.
Deborah C. Beidel, Ph.D., ABPP is Trustee Chair and Pegasus Professor of Psychology and Medical Education and Director of UCF RESTORES at the University of Central Florida. She received her Ph.D. in Clinical Psychology from the University of Pittsburgh and completed a post-doctoral fellowship in clinical research at Western Psychiatric Institute and Clinic. Dr. Beidel holds Diplomates in Clinical Psychology and Behavioral Psychology from the American Board of Professional Psychology. She is the author of over 300 scientific publications including journal articles, book chapters and books on the treatment of anxiety disorders and post- traumatic stress disorder. Dr. Beidel is the Director of UCF RESTORES, a clinical research center dedicated to trauma and PTSD. She has been the recipient of over $31 million dollars in federal research funding throughout her career. Her recent work focuses on developing effective treatments for PTSD for veterans, active duty personnel, first responders and survivors of mass shootings, utilizing technology to enhance effective treatments into standard clinical practice. Currently, she is the principal investigator of a contract from the Joint Warfighters Advanced Development Group to conduct a randomized controlled trial of three interventions for the treatment of military PTSD in active duty military personnel – including intensive outpatient programs designed to treat PTSD in two or three weeks. She also recently received another contract from the Department of Defense to develop a new virtual reality tool to allow clinicians to more easily design virtual reality scenarios for the treatment of veterans, active duty personnel, first responders, and survivors of mass shootings with PTSD.

Mr. Heinz started his IT career as a research mathematician for the National Security Agency (NSA) in 1980. In 1985, Mr. Heinz designed and programed an “intelligent signal demodulator” referencing Mercer’s theorem and implementing the Karhunen-Loveve expansion in a primitive imperative programming language created by the NSA. Mr. Heinz did not realize that he was doing “machine
learning.” In 1985, Mr. Heinz also created a software library for an implementation of the Karhunen-Loveve expansion, but now, since 2018, there are numerous implementations of the Karhunen-Loeveve expansion available (for example, from’s matlib). In 1991, Mr. Heinz received his Master’s Degree from McDaniel College in Westminster, Maryland. In 2010, Mr. Heinz saw the value in rapidly creating data planes from license-free, open-source components. As time progressed these components became more powerful and were joined by other components to augment the CI/CD of these data planes as micro services. As of 2020, Mr. Heinz is now the CEO of DFHEINZ, LLC, DUGtalks Global, and the nonprofit organization called Veterans in Artificial Intelligence.

Scroll to Top